Literature DB >> 25880241

Characterization and rapid identification of chemical constituents of NaoXinTong capsules by UHPLC-linear ion trap/Orbitrap mass spectrometry.

Wang Songsong1, Xu Haiyu2, Ma Yan2, Wang Xuguang3, Shi Yang4, Huang Bin2, Tang Shihuan2, Zhang Yi2, Li Defeng2, Liang Rixin5, Yang Hongjun6.   

Abstract

The BuChang NaoXinTong (BNC) capsule is a well-known, traditional, prescribed Chinese medication for the treatment of cardiovascular and cerebrovascular diseases. Nevertheless, the chemical profile of BNC has not been established. In the present study, ultra-high-pressure liquid chromatography coupled with linear ion trap-Orbitrap tandem mass spectrometry (UHPLC-LTQ-Orbitrap) has been developed for rapid and high-throughput screening of the preliminary chemical profile of BNC in both positive and negative ion modes. Twenty-five compounds were identified as the standard available compounds by comparing the retention time and high-resolution accurate mass. For the standard unavailable compounds, the structures were presumed based on high-accuracy protonated precursors and multi-stage mass spectrometry (MS(n)) using the proposed strategy. In particular, flavones, isoflavones, and tanshinones had the same skeleton. Therefore, the standards were utilized to characterize the fragment pathways and diagnostic fragment ions that could be applied for structural elucidation of their derivatives. Meanwhile, all the constituent groups of the compounds were detected in the individual herbs comprising BNC. Finally, a total of 178 components were identified or tentatively characterized in BNC, including 21 flavones and 6 flavone glycosides, 18 phenanthraquinones, and 22 terpenoids. The identification and structure elucidation of these chemicals provide essential data for further phytochemical studies, quality control, and pharmacological studies of BNC.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Flavones; Monoterpene glycosides; NaoXinTong capsule; Tanshinones; UHPLC-LTQ-Orbitrap

Mesh:

Substances:

Year:  2015        PMID: 25880241     DOI: 10.1016/j.jpba.2015.01.020

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  22 in total

1.  Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.

Authors:  Yan-Qiong Zhang; Qiu-Yan Guo; Qiu-Yue Li; Wei-Qiong Ren; Shi-Huan Tang; Song-Song Wang; Ri-Xin Liang; De-Feng Li; Yi Zhang; Hai-Yu Xu; Hong-Jun Yang
Journal:  Acta Pharmacol Sin       Date:  2017-08-31       Impact factor: 6.150

2.  Treatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes.

Authors:  Pu Lv; Xunliang Tong; Qing Peng; Yuanyuan Liu; Haiqiang Jin; Ran Liu; Wei Sun; Bing Pan; Lemin Zheng; Yining Huang
Journal:  Mol Med Rep       Date:  2016-01-18       Impact factor: 2.952

3.  Chemical profiling and quantification of XueBiJing injection, a systematic quality control strategy using UHPLC-Q Exactive hybrid quadrupole-orbitrap high-resolution mass spectrometry.

Authors:  Zhi Sun; Lihua Zuo; Tongwen Sun; Jinfa Tang; Daling Ding; Lin Zhou; Jian Kang; Xiaojian Zhang
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

4.  Pharmacokinetics of Caffeic Acid, Ferulic Acid, Formononetin, Cryptotanshinone, and Tanshinone IIA after Oral Administration of Naoxintong Capsule in Rat by HPLC-MS/MS.

Authors:  Jin Li; Yang Bai; Yun Bai; Ruichao Zhu; Wei Liu; Jun Cao; Mingrui An; Zhijing Tan; Yan-Xu Chang
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-05       Impact factor: 2.629

5.  Integrated metabolomics and gut microbiome to the effects and mechanisms of naoxintong capsule on type 2 diabetes in rats.

Authors:  Zenghao Yan; Hao Wu; Haokui Zhou; Shuo Chen; Yan He; Weijian Zhang; Taobin Chen; Hongliang Yao; Weiwei Su
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

6.  Analysis of Chemical Constituents of Melastoma dodecandrum Lour. by UPLC-ESI-Q-Exactive Focus-MS/MS.

Authors:  Jinfeng Wang; Ziyao Jia; Zhihao Zhang; Yutong Wang; Xi Liu; Linghua Wang; Ruichao Lin
Journal:  Molecules       Date:  2017-03-17       Impact factor: 4.411

7.  Enantioselective desymmetrization of cyclohexadienones via an intramolecular Rauhut-Currier reaction of allenoates.

Authors:  Weijun Yao; Xiaowei Dou; Shan Wen; Ji'en Wu; Jagadese J Vittal; Yixin Lu
Journal:  Nat Commun       Date:  2016-10-04       Impact factor: 14.919

8.  Up-Regulation of CYP2C19 Expression by BuChang NaoXinTong via PXR Activation in HepG2 Cells.

Authors:  Hong Sun; Xiao-Ya Lou; Xiao-Ying Wu; Huan Wang; Qiang Qu; Shen-Lan Tan; Jun-Shan Ruan; Jian Qu; Hui Chen
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

9.  Naoxintong Protects Primary Neurons from Oxygen-Glucose Deprivation/Reoxygenation Induced Injury through PI3K-Akt Signaling Pathway.

Authors:  Yan Ma; Pei Zhao; Jinqiang Zhu; Chen Yan; Lin Li; Han Zhang; Meng Zhang; Xiumei Gao; Xiang Fan
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-02       Impact factor: 2.629

10.  Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis.

Authors:  Guohua Yu; Wubin Wang; Xu Wang; Meng Xu; Lili Zhang; Lei Ding; Rui Guo; Yuanyuan Shi
Journal:  BMC Complement Altern Med       Date:  2018-11-01       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.